Search Results

You are looking at 11 - 20 of 72 items for :

  • Refine by access: All content x
Clear All
J Jääskeläinen University Department of Paediatrics, Addenbrooke’s Hospital, University of Cambridge, Hills Road CB2 2QQ, UK
University of Kuopio and Kuopio University Hospital, Department of Pediatrics, PO BOX 1777, 70211 Kuopio, Finland
MRC Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, UK

Search for other papers by J Jääskeläinen in
Google Scholar
PubMed
Close
,
A Deeb University Department of Paediatrics, Addenbrooke’s Hospital, University of Cambridge, Hills Road CB2 2QQ, UK
University of Kuopio and Kuopio University Hospital, Department of Pediatrics, PO BOX 1777, 70211 Kuopio, Finland
MRC Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, UK

Search for other papers by A Deeb in
Google Scholar
PubMed
Close
,
J W Schwabe University Department of Paediatrics, Addenbrooke’s Hospital, University of Cambridge, Hills Road CB2 2QQ, UK
University of Kuopio and Kuopio University Hospital, Department of Pediatrics, PO BOX 1777, 70211 Kuopio, Finland
MRC Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, UK

Search for other papers by J W Schwabe in
Google Scholar
PubMed
Close
,
N P Mongan University Department of Paediatrics, Addenbrooke’s Hospital, University of Cambridge, Hills Road CB2 2QQ, UK
University of Kuopio and Kuopio University Hospital, Department of Pediatrics, PO BOX 1777, 70211 Kuopio, Finland
MRC Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, UK

Search for other papers by N P Mongan in
Google Scholar
PubMed
Close
,
H Martin University Department of Paediatrics, Addenbrooke’s Hospital, University of Cambridge, Hills Road CB2 2QQ, UK
University of Kuopio and Kuopio University Hospital, Department of Pediatrics, PO BOX 1777, 70211 Kuopio, Finland
MRC Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, UK

Search for other papers by H Martin in
Google Scholar
PubMed
Close
, and
I A Hughes University Department of Paediatrics, Addenbrooke’s Hospital, University of Cambridge, Hills Road CB2 2QQ, UK
University of Kuopio and Kuopio University Hospital, Department of Pediatrics, PO BOX 1777, 70211 Kuopio, Finland
MRC Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, UK

Search for other papers by I A Hughes in
Google Scholar
PubMed
Close

control of transfection efficiency. For studies using the mammalian two-hybrid system, the pM-LBD and the pVP16-rAR-(5–538) were generous gifts from Dr Jorma Palvimo ( Ikonen et al. 1997 ; Moilanen et al. 1997 ). The pM-LBD expresses a Gal4

Free access
E Buommino
Search for other papers by E Buommino in
Google Scholar
PubMed
Close
,
D Pasquali
Search for other papers by D Pasquali in
Google Scholar
PubMed
Close
,
AA Sinisi
Search for other papers by AA Sinisi in
Google Scholar
PubMed
Close
,
A Bellastella
Search for other papers by A Bellastella in
Google Scholar
PubMed
Close
,
F Morelli
Search for other papers by F Morelli in
Google Scholar
PubMed
Close
, and
S Metafora
Search for other papers by S Metafora in
Google Scholar
PubMed
Close

Retinoic acid (RA) and sodium butyrate (NaB) are regulators of cell growth and differentiation. We studied their effect on normal (SVC1) or v-Ki-ras-transformed (Ki-SVC1) rat seminal vesicle (SV) epithelial cell lines. The treatment of these cells with 10(-((7( M RA did not produce significant changes in the morphological and biochemical parameters analyzed. When RA was used in combination with 2 mM NaB, the treatment induced substantial morphological changes, apoptosis-independent growth arrest, up-regulation of tissue transglutaminase (tTGase), and down-regulation of beta and gamma RA receptor (RAR) mRNA expression. The same cells did not express RAR alpha either before or after NaB/RA treatment. A similar treatment did not change the amount of mRNA coding for the protein SV-IV (a typical differentiation marker of the SV epithelium) in normal or ras-transformed cells nor the level of v-Ki-ras mRNA in Ki-SVC1 cells. These findings suggest that a defective RA/RARs signaling pathway is probably the biochemical condition that underlies the unresponsiveness to RA of our in vitro culture system, and indirectly points to the possibility that the NaB/RA-induced effects were brought about by a cooperation at the transcription level between the histone deacetylase inhibitory activity of NaB and the ability of RA/RAR to modulate the expression of various genes involved in the control of cell growth and differentiation.

Free access
M Schräder
Search for other papers by M Schräder in
Google Scholar
PubMed
Close
,
K M Müller
Search for other papers by K M Müller in
Google Scholar
PubMed
Close
,
M Becker-André
Search for other papers by M Becker-André in
Google Scholar
PubMed
Close
, and
C Carlberg
Search for other papers by C Carlberg in
Google Scholar
PubMed
Close

ABSTRACT

The transcription of vitamin D (VD) responsive genes is regulated by three different nuclear signalling pathways mediated by homodimers of VD receptors (VDRs), heterodimers of VDRs and retinoid X receptors (RXRs) and heterodimers of VDRs with retinoic acid receptors (RARs). Here, the in vitro DNA-binding affinity of all three receptor complexes was shown to be enhanced by the presence of VD. However, the specificity of the three pathways was dictated by the differential affinities of the receptor complexes for VD response elements. Potential response elements were distinguished by the sequence, the separation and the relative orientation of the hexameric core binding motifs. It was found that both VDR-RAR and VDR-RXR heterodimers act functionally on all three response element configurations: direct repeats, palindromes and inverted palindromes. With direct repeats, neither heterodimer type showed a preference for any of the three principal core motifs, (A/G)GGTGA, (A/G)GGTCA and (A/G)GTTCA. However, while they did exhibit preferences for core motifs in palindromes, the spacing requirements were identical for both complexes. Inverted palindromes, however, formed the most specific response elements. A simple model explains a steric link between the optimal spacing of direct repeats and that of inverted palindromes. Taken together, the experimental data and the model provide further criteria for the screening of VD responsive genes.

Restricted access
Vincent Giguère Goodman Cancer Institute and Department of Biochemistry, Faculty of Medicine, McGill University, Montréal, Québec, Canada

Search for other papers by Vincent Giguère in
Google Scholar
PubMed
Close

A and steroid hormones action. We celebrate the scientific milestone of the discovery of the retinoic acid receptor (RAR) with this special issue of the Journal of Molecular Endocrinology . This issue comprises chronicles reminiscing how that

Free access
A Stephanou
Search for other papers by A Stephanou in
Google Scholar
PubMed
Close
,
M Shah
Search for other papers by M Shah in
Google Scholar
PubMed
Close
,
B Richardson
Search for other papers by B Richardson in
Google Scholar
PubMed
Close
, and
S Handwerger
Search for other papers by S Handwerger in
Google Scholar
PubMed
Close

ABSTRACT

Studies were performed to determine whether ARP-1, which is an orphan receptor of the steroid receptor superfamily, inhibits basal activity of the human placental lactogen (hPL) promoter and the increase in hPL promoter activity in response to the receptors for thyroid hormone (TR) and retinoic acid (RAR). Co-transfection of an ARP-1 expression vector into BeWo choriocarcinoma cells, along with an expression vector containing 1·2 kb of the hPL promoter coupled to a CAT reporter gene, resulted in a dose-dependent inhibition of basal CAT activity. In addition, ARP-1 inhibited the stimulation of CAT activity by RARα and TRβ expression vectors. Mobility shift assays demonstrated that ARP-1 binds specifically to a composite steroid response element on the hPL promoter that confers retinoic acid and T3 responsiveness. The results implicate an inhibitory role for ARP-1 in the regulation of hPL gene expression and strongly suggest that hPL gene expression is regulated, at least in part, by the interaction of stimulatory and inhibitory members of the steroid receptor superfamily.

Restricted access
S Mailfait
Search for other papers by S Mailfait in
Google Scholar
PubMed
Close
,
E Thoreau
Search for other papers by E Thoreau in
Google Scholar
PubMed
Close
,
D Belaiche
Search for other papers by D Belaiche in
Google Scholar
PubMed
Close
, and
P Formstecher And B Sablonnie
Search for other papers by P Formstecher And B Sablonnie in
Google Scholar
PubMed
Close

The pleiotropic effects of the natural and synthetic retinoids are mediated by the activation of the two subfamilies of nuclear receptors, the retinoic acid receptors (RARs) and the retinoic X receptors (RXRs). At the molecular level, these events begin with the specific ligand recognition by a nuclear receptor subtype. The adaptation of ligands to the receptor binding site leads to an optimal number of interactions for binding and selectivity which justifies elucidation of the structural requirements of the ligand binding pocket. To explore the contribution of H6-H7 loop folding in the ligand-induced conformational changes explained by the mouse-trap model, four RARalpha mutants were constructed. Ligand binding and transactivation studies revealed that three residues from the H6-H7 loop (Gly(301), Phe(302) and Gly(303)) are critical for the conformational adaptation of both synthetic agonists and antagonists. Model building and analysis of both RARalpha-ATRA and RARalpha-CD367 complexes demonstrate that accommodation of CD367 results in a less tight contact of the saturated ring of this ligand with the amino acid side chains of the receptor ligand-binding pocket compared with that of ATRA. According to the flexibility of the agonists tested (ATRA>TTNPB=Am580> CD367), we observed a decrease in binding that was dependent on ligand structure rigidity. In contrast, the binding and transactivating activities of the L266A mutant confirmed the structural constraints imposed by synthetic ligands on binding affinity for the receptor and revealed that subtle local rearrangements induced by specific conformational adaptation changes result in different binding affinities. Our results illustrate the dynamic nature of the interaction between RARalpha and its ligands and demonstrate the critical role of the H6-H7 loop in the binding of both synthetic retinoid agonists and antagonists.

Free access
S Yamaguchi
Search for other papers by S Yamaguchi in
Google Scholar
PubMed
Close
,
Y Murata
Search for other papers by Y Murata in
Google Scholar
PubMed
Close
,
T Nagaya
Search for other papers by T Nagaya in
Google Scholar
PubMed
Close
,
Y Hayashi
Search for other papers by Y Hayashi in
Google Scholar
PubMed
Close
,
S Ohmori
Search for other papers by S Ohmori in
Google Scholar
PubMed
Close
,
Y Nimura
Search for other papers by Y Nimura in
Google Scholar
PubMed
Close
, and
H Seo
Search for other papers by H Seo in
Google Scholar
PubMed
Close

We have previously demonstrated that dexamethasone (DEX) enhances the T3-dependent increase in type I 5'-deiodinase (5'DI) mRNA in primary cultured rat hepatocytes grown as spheroids. Here we report that DEX-enhanced T3-responsiveness also occurs in two other T3-regulated hepatic genes, Spot 14 and malic enzyme. This enhancement was inhibited by pretreatment with cycloheximide and the stability of 5'DI and Spot 14 mRNAs was not affected by DEX. We thus hypothesized that a factor(s) that augments T3-responsiveness is induced by DEX. Among the possible candidates examined, retinoid-X receptor alpha (RXRalpha), which is a main heterodimer partner with T3 receptor, appeared to be involved. Whereas DEX increased the amount of RXRalpha mRNA, it did not affect the expression of other possible factors such as steroid receptor coactivator-1 and the binding protein of cAMP response element-binding protein. Northern and Western blot analysis, and electrophoretic mobility shift assay revealed that DEX increased RXRalpha expression at both the mRNA and protein levels. Maximal increase in RXRalpha protein was achieved with the addition of physiological concentrations of DEX (10(-8) M). To test whether the DEX-induced increase in RXRalpha affects ligand-dependent transcriptional activation through other receptors that form heterodimer with RXR, we examined its effect on the retinoic acid (RA)/RA receptor (RAR) system. Indeed, DEX also enhanced the RA-dependent increase in RARbeta mRNA in a cycloheximide-sensitive manner. Increase in the level of RXRalpha in hepatocytes by infection with the RXRalpha-expressing adenovirus resulted in enhancement of the T3-dependent increase in 5'DI mRNA. These results strongly suggest that the DEX-induced augmentation of T3-responsiveness in cultured hepatocytes is mediated, in part, by the increased expression of RXRalpha.

Free access
V Laudet
Search for other papers by V Laudet in
Google Scholar
PubMed
Close

From a database containing the published nuclear hormone receptor (NR) sequences I constructed an alignment of the C, D and E domains of these molecules. Using this alignment, I have performed tree reconstruction using both distance matrix and parsimony analysis. The robustness of each branch was estimated using bootstrap resampling methods. The trees constructed by these two methods gave congruent topologies. From these analyses I defined six NR subfamilies: (i) a large one clustering thyroid hormone receptors (TRs), retinoic acid receptors (RARs), peroxisome proliferator-activated receptors (PPARs), vitamin D receptors (VDRs) and ecdysone receptors (EcRs) as well as numerous orphan receptors such as RORs or Rev-erbs; (ii) one containing retinoid X receptors (RXRs) together with COUP, HNF4, tailless, TR2 and TR4 orphan receptors; (iii) one containing steroid receptors; (iv) one containing the NGFIB orphan receptors; (v) one containing FTZ-F1 orphan receptors; and finally (vi) one containing to date only one gene, the GCNF1 orphan receptor. The relationships between the six subfamilies are not known except for subfamilies I and IV which appear to be related. Interestingly, most of the liganded receptors appear to be derived when compared with orphan receptors. This suggests that the ligand-binding ability of NRs has been gained by orphan receptors during the course of evolution to give rise to the presently known receptors. The distribution into six subfamilies correlates with the known abilities of the various NRs to bind to DNA as homo- or heterodimers. For example, receptors heterodimerizing efficiently with RXR belong to the first or the fourth subfamilies. I suggest that the ability to heterodimerize evolved once, just before the separation of subfamilies I and IV and that the first NR was able to bind to DNA as a homodimer. From the study of NR sequences existing in vertebrates, arthropods and nematodes, I define two major steps of NR diversification: one that took place very early, probably during the multicellularization event leading to all the metazoan phyla, and a second occurring later on, corresponding to the advent of vertebrates. Finally, I show that in vertebrate species the various groups of NRs accumulated mutations at very different rates.

Restricted access
You-Hong Cheng
Search for other papers by You-Hong Cheng in
Google Scholar
PubMed
Close
,
Hiroki Utsunomiya Department of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, 303 East Superior Street, Suite 4-131, Chicago, Illinois 60611-3095, USA

Search for other papers by Hiroki Utsunomiya in
Google Scholar
PubMed
Close
,
Mary Ellen Pavone
Search for other papers by Mary Ellen Pavone in
Google Scholar
PubMed
Close
,
Ping Yin
Search for other papers by Ping Yin in
Google Scholar
PubMed
Close
, and
Serdar E Bulun
Search for other papers by Serdar E Bulun in
Google Scholar
PubMed
Close

al . 1995 , Meyer et al . 1996 , Morriss-Kay & Ward 1999 , Bastien & Rochette-Egly 2004 ). The RA signal is transduced by members of two families of nuclear hormone receptors, the RA receptors (RARs) and the retinoid X receptors (RXRs; Meyer et

Free access
Jan Wilde Institute for Biochemistry II, Jena University Hospital, Friedrich Schiller University Jena, Nonnenplan 4,
07743 Jena, Germany

Search for other papers by Jan Wilde in
Google Scholar
PubMed
Close
,
Maria Erdmann Institute for Biochemistry II, Jena University Hospital, Friedrich Schiller University Jena, Nonnenplan 4,
07743 Jena, Germany

Search for other papers by Maria Erdmann in
Google Scholar
PubMed
Close
,
Michael Mertens Institute for Biochemistry II, Jena University Hospital, Friedrich Schiller University Jena, Nonnenplan 4,
07743 Jena, Germany

Search for other papers by Michael Mertens in
Google Scholar
PubMed
Close
,
Gabriele Eiselt Institute for Biochemistry II, Jena University Hospital, Friedrich Schiller University Jena, Nonnenplan 4,
07743 Jena, Germany

Search for other papers by Gabriele Eiselt in
Google Scholar
PubMed
Close
, and
Martin Schmidt Institute for Biochemistry II, Jena University Hospital, Friedrich Schiller University Jena, Nonnenplan 4,
07743 Jena, Germany

Search for other papers by Martin Schmidt in
Google Scholar
PubMed
Close

aromatase expression in breast adipose fibroblasts (BAFs). In this study, we show that ligands of the retinoic acid receptors (RARs), all- trans -RA (at-RA) and 9- cis -RA (9 cis -RA), induce aromatase activity in human BAFs via a retinoic acid response

Free access